Toxic effects of Vitamin C combined with temozolomide on glioma cells and its mechanism

doi:10.12047/j.cjap.5958.2020.129

Abstract

Abstract: Objective: To investigate the toxic effects of vitamin C (VC) combined with temozolomide (TMZ) on gliomas and its mechanism. Methods: Human glioma cells BMG-1 and SHG44 cells were cultured in vitro, specifically divided into control group (without VC and TMZ), TMZ group (0.2 mmol/L), VC (0.5 mmol/L)+TMZ(0.2 mmol/L) group and TMZ(0.2 mmol/L TMZ)+U0126(10 μmol/L)group, each experiment was repeated three times. Cell survival rate was detected by MTT assay; Cell apoptosis was detected by flow cytometry and Annexin V-FITC/PI staining; Reactive oxygen species (ROS) levels were detected by ROS detection kit, and Western blot was used to detect the expression levels of proteins related to apoptosis, autophagy and ERK pathway. Results: Compared with the control group, the survival rate of glioma cells in the TMZ group was decreased significantly(P＜0.05). Compared with the TMZ group, the survival rate of glioma cells in the VC+TMZ group was decreased significantly(P＜0.01), the cell apoptosis rate was increased, and the expressions of Bax, Cleaved caspase-3 and Cleaved PARP protein were increased, while the expression of Bcl-2 was decreased. The ROS level and autophagy rate were decreased, while the expression of LC3-II/LC3-1 was decreased, and the expression of p62 was increased in the VC+TMZ group (all P＜0.05). At the same time, VC combined with TMZ decreased the expression level of p-ERK1/2-related protein in BMG-1 and SHG44 cells, and increased the apoptosis rate (P＜0.05). Conclusion: VC combined with temozolomide can enhance the toxicity of glioma cells. This effect is to promote apoptosis and inhibit temozolomide-mediated autophagy through the regulation of the ERK signaling pathway.

Key words: vitamin C (VC), temozolomide (TMZ), glioma, reactive oxygen species (ROS), cell toxicity

CLC Number:

R739.41

CHEN Ming-sheng, ZHAO Hai-kang, CHENG Ying-ying, YUAN Zhi-hai, ZHANG Yue-lin. Toxic effects of Vitamin C combined with temozolomide on glioma cells and its mechanism[J]. CJAP, 2020, 36(6): 616-621.

References

[1] Chang L, Su J, Jia X, et al. Treating malignant glioma in chinese patients: Update on temozolomide[J]. Onco Targets Ther, 2014, 7(1): 235-244.
[2] Huang Q, Dong J, Zhu YD, et al. Isolation and culture of tumor stem cells from human brain glioma tissues[J]. Chin J Oncol, 2006, 28(5): 331-333.
[3] Zheng R, Fan R, Wen H, et al. Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas[J]. J Buon, 2015, 20(1): 248-252.
[4] Milano MT, Constine LS, Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs[J]. Semin Radiat Oncol, 2007, 17(2): 131-140.
[5] Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene and the clinical response of gliomas to alkylating agents[J]. N Engl J Med, 2000, 343(19): 1350-1354.
[6] Rosso L, Brock CS, Gallo JM, et al. A new model for prediction of drug distribution in tumor and normal tissues: Pharmacokinetics oftemozolomide in glioma patients[J]. Cancer Res, 2009, 69(1): 120-127.
[7] Chang-Halpenny CN, Yeh J, Lien WW. Elderly patients with glioblastoma multiforme treated with concurrent temozolomide and standard- versus abbreviated-course radiotherapy[J]. Perm J, 2015, 19(1): 15-20.
[8] Jo MY, Kim YG, Kim Y, et al. Combined therapy oftemozolomide and zd6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms[J]. Mol Med Rep, 2012, 6(1): 88-92.
[9] Duan L, Wu XL, Zhao F, et al. Induction effect to apoptosis by maitake polysaccharide: Synergistic effect of its combination with vitamin c in neuroglioma cell[J]. J Evid Based Complement Altern Med, 2017, 22(4): 667-674.
[10] Gao KF, Zeng G, Gynecology DO. Role of vitamin C as a sensitizer for arsenic trioxide in epithelial ovarian cancer cells[J]. Hainan Medical Journal, 2014, 25(16): 2350-2353.
[11] Monti D, Newberg A, Littman SJ, et al. Intravenous vitamin C in combination with gemcitabine and erlotinib in subjects with metastatic pancreatic cancer[J]. Aids, 2011, 95(1): 447-454.
[12] Vita MF, Nagachar N, Avramidis D, et al. Pankiller effect of prolonged exposure to menadione on glioma cells: Potentiation by vitamin C[J]. Invest New Drugs, 2011, 29(6): 1314-1320.
[13] 孔晓霞, 张宏宇, 陈然, 等. 神经胶质瘤U251细胞氧化损伤中自噬和凋亡过程中的时间顺序[J]. 中国应用生理学杂志, 2011, 27(4): 471-474.
[14] Hervey-Jumper SL, Berger MS. Role of surgical resection in low- and high-grade gliomas[J]. Curr Treat Options Neuro, 2014, 16(4): 284-302.
[15] Ortega-Liebana MC, Encabo-Berzosa MM, Ruedas-Rama MJ, et al. Nitrogen-induced transformation of vitamin C into multifunctional up-converting carbon nanodots in the visible-nir range[J]. Chemistry, 2017, 23(13): 3067-3073.
[16] Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352(10): 987-996.
[17] Baumann F, Bjeljac M, Kollias SS, et al. Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme[J]. Neuro Oncol, 2004, 67(1): 191-200.
[18] Chen Q, Espey MG, Krishna MC, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues[J]. Proc Natl Acad Sci USA, 2005,102(38): 13604-13609.
[19] Naidu KA, Tang JL, Naidu KA, et al. Anti-proliferative and apoptotic effect of ascorbyl stearate in human glioblastomamultiforme cells: Modulation of insulin-like growth factor-i receptor (igf-ir) expression[J]. Neuro Oncol, 2001, 54(1): 15-22.
[20] Zheng QS, Zhang YT, Zheng RL. Ascorbic acid induces re-differentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide[J]. Pharmazie, 2002, 57(11): 753-757.
[21] Rodriguez FS, Salazar KA, Jara NA, et al. Superoxide-dependent uptake of vitamin C in human glioma cells[J]. J Neurochemistry, 2013, 127(6): 793-804.
[22] Leon IE, Di Virgilio AL, Porro V, et al. Antitumor properties of a vanadyl(iv) complex with the flavonoid chrysin [vo(chrysin)2etoh] 2 in a human osteosarcoma model: The role of oxidative stress and apoptosis[J]. Dalton Trans, 2013, 42(33): 11868-11880.
[23] de Souza Grinevicius VM, Kviecinski MR, Santos Mota NS, et al. Piper nigrumethanolic extract rich in piperamides causes ros overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells[J]. J Ethno pharmacol, 2016, 189(16): 139-147.
[24] 吕小生, 陈旭义, 汤锋武, 等. 亚硒酸钠对脑胶质瘤干细胞生长抑制效应及细胞内活性氧的影响[J]. 中国应用生理学杂志, 2013, 29(1): 80-81.
[25] Chen P, Yu J, Chalmers B, et al. Pharmacological ascorbate induces cytotoxicity in prostate cancer cells throughATP depletion and induction of autophagy[J]. Anticancer, 2012, 23(4): 437-444.
[26] Aguilera O, Munoz-Sagastibelza M, Torrejon B, et al. Vitamin C uncouples the warburg metabolic switch in kras mutant colon cancer[J]. Oncotarget, 2016, 7(30): 47954-47965.
[27] Lin CJ, Lee CC, Shih YL, et al. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy[J]. Free RadicBiol Med, 2012, 52(2): 377-391.